Joseph M Connors. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntigens, CD20/immunologyHumansLymphoma, Follicular/radiotherapyRadioimmunotherapyTreatment Outcome
Substances: See more » Antibodies, MonoclonalAntigens, CD20tositumomab I-131
Year: 2005 PMID: 15689589 DOI: 10.1056/NEJMe048291
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245